13F Notebook
← Dashboard
Fund detail

Baillie Gifford

large-active, growth, lo

Quarters 52
2017-03-31 $68.72B
Positions 200
Showing 13 of 13 rows (filtered from 211)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 Qiagen N.V $209.5M 0.30% 7,230,620 +7,230,620 2017-03-31 $29 ~$29 +0.00%
2 MakeMyTrip $80.6M 0.12% 2,329,489 +2,329,489 2013-09-30 $35 ~$24 +45.65%
3 Albemarle Corp ALB $9.7M 0.01% 91,905 +91,905 2017-03-31 $106 ~$106 +0.00%
4 Teladoc TDOC $5.1M 0.01% 203,000 +203,000 2017-03-31 $25 ~$25 +0.00%
5 Ambarella $4.9M 0.01% 89,100 +89,100 2017-03-31 $55 ~$55 +0.00%
6 Mindbody Cl A $4.5M 0.01% 165,261 +165,261 2017-03-31 $27 ~$27 +0.00%
7 Blackstone/GSO Strategic Credit Fund BGB $2.0M 0.00% 128,690 +128,690 2017-03-31 $16 ~$16 +0.00%
8 Nuveen Credit Strategies Income Fund XJQCX $2.0M 0.00% 230,900 +230,900 2017-03-31 $9 ~$9 +0.00%
9 Baozun Spn.Adr 1:1 BZUN $1.6M 0.00% 106,132 +106,132 2017-03-31 $15 ~$15 +0.00%
10 CEVA Inc CEVA $1.5M 0.00% 42,847 +42,847 2017-03-31 $35 ~$35 +0.00%
11 Xylem XYL $274K 0.00% 5,457 +5,457 2017-03-31 $50 ~$50 +0.00%
12 Ecolab ECL $254K 0.00% 2,027 +2,027 2013-09-30 $125 ~$99 +26.88%
13 Kite Pharma $201K 0.00% 2,564 +2,564 2017-03-31 $78 ~$78 +0.00%